https://www.selleckchem.com/products/ms-275.html
8 mg QD in delaying gastric emptying, as assessed by acetaminophen PK (lower bound of 90% CI for the efpeglenatideliraglutide ratio 0.8 for area under the curve (AUC) , AUC , AUC and maximum concentration (C )). Efpeglenatide 16 mg QM did not decrease the rate of gastric emptying to as great an extent as liraglutide (ie, non-inferiority was not shown). Compared with liraglutide, both efpeglenatide dosing regimens demonstrated comparable or more favorable glucometabolic effects and improved beta-cell function. All gastrointestinal adv
Like
Comment
Share
